Deutsche Bank Aktiengesellschaft Has Lowered Expectations for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CME) had its price target cut by Deutsche Bank Aktiengesellschaft from $227.00 to $226.00 in a research note published on Monday,Benzinga reports. They currently have a hold rating on the financial services provider’s stock.

Several other brokerages have also recently weighed in on CME. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Morgan Stanley upped their price target on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Barclays boosted their price objective on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Bank of America boosted their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research note on Thursday, October 3rd. Finally, Citigroup boosted their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $224.47.

CME Group Price Performance

CME Group stock opened at $225.93 on Monday. The firm has a 50-day moving average of $221.72 and a two-hundred day moving average of $209.84. CME Group has a 1 year low of $190.70 and a 1 year high of $230.36. The stock has a market cap of $81.36 billion, a price-to-earnings ratio of 23.76, a price-to-earnings-growth ratio of 5.68 and a beta of 0.55. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the company earned $2.25 EPS. The company’s revenue was up 18.4% compared to the same quarter last year. On average, research analysts forecast that CME Group will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. CME Group’s payout ratio is 48.37%.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by corporate insiders.

Institutional Trading of CME Group

A number of hedge funds have recently added to or reduced their stakes in CME. Y.D. More Investments Ltd purchased a new position in CME Group during the second quarter valued at $36,000. McClarren Financial Advisors Inc. lifted its holdings in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC lifted its holdings in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares in the last quarter. Finally, Bank & Trust Co purchased a new position in CME Group during the second quarter valued at $76,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.